Skip to content

Aortic Stenosis Associated Left Ventricular Remodeling - An Investigation of Genetic and Gender Specific Differences in 170 Patients Undergoing Aortic Valve Replacement Surgery

Aortic Stenosis Associated Left Ventricular Remodeling - Impact of Genetic, Valvular and Non-valvular Factors

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05696145
Acronym
SALVAGE
Enrollment
170
Registered
2023-01-25
Start date
2023-03-01
Completion date
2025-01-31
Last updated
2023-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Valve Stenosis

Keywords

low flow low gradient aortic valve stenosis

Brief summary

The goal of this study is to investigate the genetic and gender specific differences, in patients with low flow low gradient aortic stenosis and high flow high gradient aortic stenosis. Patients referred for surgical aorticvalve replacement will be offered to participarte in the study. The main questions the study aims to answer are: 1. Low-gradient aortic stenosis is associated with differences in valvular concentration of the genes that code for mast-cell chymase, Angiotensin-II, ACE, ACE2 and Angiotensin receptor 1 and 2. 2. Low-gradient aortic stenosis is associated with differences in the genetic code of renin-angiotensin-aldosterone system. 3. Gender differences in LV remodelling associates with different levels of sexual hormones. Patients participating in the study will be asked to undergo: * Cardiac ultrasound, MR- and CT-scan prior to surgery * Blooddraw prior to surgery. * Heartmuscle biopsy during surgery * Cardiac MR-scan 1 year after surgery.

Interventions

None listed

Sponsors

Lisa Gundestrup
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Severe AS (estimated by the local heart team, aortic valve area\<1cm2) referred for AVR at the cardiology department at Odense University Hospital 2. Age \> 18 years 3. Signed informed consent

Exclusion criteria

1. Bicuspid aortic valve. 2. LV systolic dysfunction (LVEF\<50%). 3. Patients with concomitant moderate-severe aortic valve regurgitation. 4. Concomitant moderate-severe mitral valve regurgitation. 5. Moderate to severe nephropathy (s-creatinine \>200 mmol/l) 6. Unwilling to participate in the study. 7. Claustrophobia. 8. Permanent cardiac devices (pacemaker and ICD)

Design outcomes

Primary

MeasureTime frame
Genetic polymorphisms betweem low flow low gradient and high flow high gradient aortic stenosis patientsAt the time of surgery

Contacts

Primary ContactLisa Gundestrup, MD
lisa.gundestrup@rsyd.dk+4530563464

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026